Literature DB >> 22188517

The oncogenic TBC domain protein USP6/TRE17 regulates cell migration and cytokinesis.

Christine Rueckert1, Volker Haucke.   

Abstract

BACKGROUND INFORMATION: Cancer cells are characterized by their intrinsic ability to rapidly divide and migrate and to invade other tissues. How these processes are regulated at a molecular level is largely unknown.
RESULTS: Here, we identify the oncogenic TBC (Tre-2/Bub2/Cdc16) domain protein USP6 (also termed TRE17) as a regulator of both cell migration and division. We show that manipulating USP6 expression levels alters the ability of cells to migrate and to divide. Furthermore, we observe that cell proliferation and progression through cytokinesis depend on USP6 expression via a pathway that involves the small GTPase Arf6 and its GTPase-activating protein ACAP1.
CONCLUSIONS: Our data suggest a model whereby the oncogenic potential of USP6 is linked to its ability to integrate cell migration and cytokinesis by regulating Arf6/ACAP1.
Copyright © 2012 Soçiété Francaise des Microscopies and Société de Biologie Cellulaire de France.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22188517     DOI: 10.1111/boc.201100108

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  10 in total

1.  TRE17/USP6 regulates ubiquitylation and trafficking of cargo proteins that enter cells by clathrin-independent endocytosis.

Authors:  Yuji Funakoshi; Margaret M Chou; Yasunori Kanaho; Julie G Donaldson
Journal:  J Cell Sci       Date:  2014-09-01       Impact factor: 5.285

2.  USP6 Confers Sensitivity to IFN-Mediated Apoptosis through Modulation of TRAIL Signaling in Ewing Sarcoma.

Authors:  Ian C Henrich; Robert Young; Laura Quick; Andre M Oliveira; Margaret M Chou
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

3.  USP19 Enhances MMP2/MMP9-Mediated Tumorigenesis in Gastric Cancer.

Authors:  Zhe Dong; Shuai Guo; Yue Wang; Jun Zhang; Haojie Luo; Guoliang Zheng; Dong Yang; Tao Zhang; Liucun Yan; Li Song; Kejia Liu; Zhe Sun; Xiangyu Meng; Zhichao Zheng; Jianjun Zhang; Yan Zhao
Journal:  Onco Targets Ther       Date:  2020-08-24       Impact factor: 4.147

4.  TBC1D2 Promotes Ovarian Cancer Metastasis via Inducing E-Cadherin Degradation.

Authors:  Jiming Tian; Xiaolei Liang; Dalin Wang; Jinglin Tian; Haiping Liang; Ting Lei; Zeyu Yan; Dan Wu; Xiaoli Liu; Shujuan Liu; Yongxiu Yang
Journal:  Front Oncol       Date:  2022-04-27       Impact factor: 5.738

Review 5.  Giant cell lesions of the craniofacial bones.

Authors:  Adrienne M Flanagan; Paul M Speight
Journal:  Head Neck Pathol       Date:  2014-11-20

6.  Mutation of TBCK causes a rare recessive developmental disorder.

Authors:  Rita J Guerreiro; Rachel Brown; Donnai Dian; Christian de Goede; Jose Bras; Sara E Mole
Journal:  Neurol Genet       Date:  2016-05-24

7.  TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.

Authors:  Fabia Fricke; Jennifer Lee; Malwina Michalak; Uwe Warnken; Ingrid Hausser; Meggy Suarez-Carmona; Niels Halama; Martina Schnölzer; Jürgen Kopitz; Johannes Gebert
Journal:  Cell Commun Signal       Date:  2017-04-04       Impact factor: 5.712

8.  Tre2 (USP6NL) promotes colorectal cancer cell proliferation via Wnt/β-catenin pathway.

Authors:  Kang Sun; Song-Bing He; Yi-Zhou Yao; Jian-Guo Qu; Rong Xie; Yu-Qiao Ma; Ming-Hui Zong; Ji-Xiang Chen
Journal:  Cancer Cell Int       Date:  2019-04-16       Impact factor: 5.722

9.  Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.

Authors:  Ning Wang; Lingye Zhu; Xiaomei Xu; Chang Yu; Xiaoying Huang
Journal:  Comput Struct Biotechnol J       Date:  2022-08-13       Impact factor: 6.155

10.  Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases.

Authors:  Zoltán Sápi; Zoltán Lippai; Gergő Papp; Lajos Hegyi; Johanna Sápi; Katalin Dezső; Károly Szuhai
Journal:  Mod Pathol       Date:  2021-08-11       Impact factor: 7.842

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.